LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics
about
Gene expression in systemic lupus erythematosus: Bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signaturesEfalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindranceThe wild boar (Sus scrofa) lymphocyte function-associated antigen-1 (CD11a/CD18) receptor: cDNA sequencing, structure analysis and comparison with homologuesEvidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro.Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond.Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction.LFA-1 on leukemic cells as a target for therapy or drug delivery.Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.Lymphatic endothelial murine chloride channel calcium-activated 1 is a ligand for leukocyte LFA-1 and Mac-1.Anti-LFA-1 antibodies enhance metastasis of ocular lymphoma to the brain and contralateral eye.Profiling CD antigens on leukaemias with an antibody microarray.Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.Epigenetics and psoriasis.Adaptor regulation of LFA-1 signaling in T lymphocyte migration: Potential druggable targets for immunotherapies?Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.A mechanism for antibody-mediated outside-in activation of LFA-1.Cordyceps sinensis promotes immune regulation and enhances bacteriostatic activity of PA-824 via IL-10 in Mycobacterium tuberculosis disease.2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.SHP-1 Acts as a Key Regulator of Alloresponses by Modulating LFA-1-Mediated Adhesion in Primary Murine T Cells.A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Inflammation and Cancer: In Medio Stat Nano.Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.
P2860
Q27490156-5DCDB342-61AF-4AC5-9695-5E1E1945A899Q27654007-9C5830B8-5C6A-46BE-9452-2D5A5386F4D1Q33302692-DA80E4E5-EB44-405E-9894-7F9E17E96636Q33321955-A1BD806C-024A-4D6F-90BA-1FCFDAC17DC9Q33643660-02EA4B2F-4C82-44C3-9B9B-1763D131AA8DQ34236804-BB36B60C-731F-4853-82CF-4DA648773363Q34394850-18B984C8-6F1C-4D7E-B9CC-CEF480655503Q35082436-9480CA78-F1AF-4C3F-A90B-7941D92356D2Q36009146-35206230-DF3B-4461-A545-D6C359B232FEQ36485672-C50EA16A-1ACC-4A2B-9733-A22A324B5484Q37418300-D62368E0-1C37-4724-98E7-CB4EEBDEF2E5Q37673703-F0C05339-B563-4FF2-B9F6-FA5CF4F1BA0FQ37933446-53733973-84EB-4995-AFB7-F6BFE559648CQ38253927-002C5E1B-E265-47C4-8602-97FA42071540Q39559416-703B3EF2-47BE-4EF3-8A8E-9AE923003BAFQ40024433-E2D87D7B-117F-44CA-8944-4E674919B7D8Q40100208-B44B2DAA-7C32-489B-A9BF-47789635C763Q41892335-99651E7B-8864-4781-8DF4-52C2A087AA5FQ42362489-BCBD9AF0-8FEA-46D1-A3D4-8E9B885257C6Q43200676-AA96599E-2BFB-4424-84A8-9ED937924477Q47783708-6C3A2751-FAEE-4E40-8E73-14F106E0155CQ47877048-DB02356B-5257-4B9C-8C86-DB0233E92ECFQ50192022-700238EE-2E4B-4B8E-A5EB-37F7EB8061C9
P2860
LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@ast
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@en
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@nl
type
label
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@ast
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@en
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@nl
prefLabel
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@ast
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@en
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@nl
P1476
LFA-1 as a key regulator of im ...... nt of LFA-1-based therapeutics
@en
P2093
P A Giblin
R M Lemieux
P304
P356
10.2174/138161206777947731
P407
P577
2006-01-01T00:00:00Z